{"entity":{"type":"insider","cik":"0001454996","url":"/insider/0001454996","json_url":"/insider/0001454996.json","name":"Ozeroff Christopher David","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":7,"first":"2015-09-21","last":"2021-11-23","span_basis":"filed_date"},"name_variants":[{"name":"Ozeroff Christopher David","source":"filing","n_filings":7,"first_seen":"2015-09-21","last_seen":"2021-11-23"}],"transactions":[{"id":5385207,"accession":"0001209191-21-066497","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-066497","line_url":"/filing/0001209191-21-066497#line-1","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":"0001454996","owner_name":"Ozeroff Christopher David","owner_display_name":"Ozeroff Christopher David","owner_url":"/insider/0001454996","role":"Officer (S.V.P., General Counsel)","role_mark":"O","role_mark_label":"Officer (S.V.P., General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"S.V.P., General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":2.2642,"price_display":"2.26","price_state":"stated","total_value":113210.0,"total_display":"113,210.00","total_whole":"113,210","shares_owned_after":50970.0,"shares_owned_after_display":"50,970","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-22","filed_date":"2021-11-23","scope":"insider"},{"id":5067373,"accession":"0001209191-17-025622","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-025622","line_url":"/filing/0001209191-17-025622#line-1","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":"0001454996","owner_name":"Ozeroff Christopher David","owner_display_name":"Ozeroff Christopher David","owner_url":"/insider/0001454996","role":"Officer (S.V.P., General Counsel)","role_mark":"O","role_mark_label":"Officer (S.V.P., General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"S.V.P., General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":418.0,"shares_display":"418","price_per_share":2.41,"price_display":"2.41","price_state":"stated","total_value":1007.38,"total_display":"1,007.38","total_whole":"1,007","shares_owned_after":17517.0,"shares_owned_after_display":"17,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-04","filed_date":"2017-04-05","scope":"insider"},{"id":5033306,"accession":"0001209191-17-015984","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-015984","line_url":"/filing/0001209191-17-015984#line-1","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":"0001454996","owner_name":"Ozeroff Christopher David","owner_display_name":"Ozeroff Christopher David","owner_url":"/insider/0001454996","role":"Officer (S.V.P., General Counsel)","role_mark":"O","role_mark_label":"Officer (S.V.P., General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"S.V.P., General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":465.0,"shares_display":"465","price_per_share":2.61,"price_display":"2.61","price_state":"stated","total_value":1213.65,"total_display":"1,213.65","total_whole":"1,214","shares_owned_after":17935.0,"shares_owned_after_display":"17,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-28","filed_date":"2017-03-01","scope":"insider"},{"id":2668124,"accession":"0001209191-16-142259","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-142259","line_url":"/filing/0001209191-16-142259#line-1","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":"0001454996","owner_name":"Ozeroff Christopher David","owner_display_name":"Ozeroff Christopher David","owner_url":"/insider/0001454996","role":"Officer (S.V.P., General Counsel)","role_mark":"O","role_mark_label":"Officer (S.V.P., General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"S.V.P., General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1185.0,"shares_display":"1,185","price_per_share":2.89,"price_display":"2.89","price_state":"stated","total_value":3424.65,"total_display":"3,424.65","total_whole":"3,425","shares_owned_after":18400.0,"shares_owned_after_display":"18,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-20","filed_date":"2016-09-21","scope":"insider"},{"id":2902205,"accession":"0000899243-16-017727","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-017727","line_url":"/filing/0000899243-16-017727#line-1","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":"0001454996","owner_name":"Ozeroff Christopher David","owner_display_name":"Ozeroff Christopher David","owner_url":"/insider/0001454996","role":"Officer (S.V.P., General Counsel)","role_mark":"O","role_mark_label":"Officer (S.V.P., General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"S.V.P., General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":366.0,"shares_display":"366","price_per_share":3.52,"price_display":"3.52","price_state":"stated","total_value":1288.32,"total_display":"1,288.32","total_whole":"1,288","shares_owned_after":19585.0,"shares_owned_after_display":"19,585","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-05","filed_date":"2016-04-06","scope":"insider"},{"id":2862119,"accession":"0000899243-16-014987","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-014987","line_url":"/filing/0000899243-16-014987#line-1","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":"0001454996","owner_name":"Ozeroff Christopher David","owner_display_name":"Ozeroff Christopher David","owner_url":"/insider/0001454996","role":"Officer (S.V.P., General Counsel)","role_mark":"O","role_mark_label":"Officer (S.V.P., General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"S.V.P., General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":458.0,"shares_display":"458","price_per_share":3.51,"price_display":"3.51","price_state":"stated","total_value":1607.58,"total_display":"1,607.58","total_whole":"1,608","shares_owned_after":19951.0,"shares_owned_after_display":"19,951","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-01","filed_date":"2016-03-02","scope":"insider"},{"id":8894749,"accession":"0000899243-15-005095","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-15-005095","line_url":"/filing/0000899243-15-005095#line-1","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":"0001454996","owner_name":"Ozeroff Christopher David","owner_display_name":"Ozeroff Christopher David","owner_url":"/insider/0001454996","role":"Officer (S.V.P., General Counsel)","role_mark":"O","role_mark_label":"Officer (S.V.P., General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"S.V.P., General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1129.0,"shares_display":"1,129","price_per_share":6.32,"price_display":"6.32","price_state":"stated","total_value":7135.28,"total_display":"7,135.28","total_whole":"7,135","shares_owned_after":20409.0,"shares_owned_after_display":"20,409","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-18","filed_date":"2015-09-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000907654","name":"ARCA biopharma, Inc.","url":"/issuer/0000907654","role":"Officer (S.V.P., General Counsel)","n_filings":7,"first_seen":"2015-09-21","last_seen":"2021-11-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001454996","retrieved_at":"2026-08-26T15:33:41+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}